During the past decade, Ausl Di Piacenza conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ausl Di Piacenza" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 6 trials, followed by "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 3 trials sponsored, "Canadian Cancer Trials Group" with 2 trials sponsored, "Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori" with 2 trials sponsored and "Azienda Unità Sanitaria Locale Reggio Emilia" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ausl Di Piacenza" #1 collaborator was "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator and "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Ausl Di Piacenza" are "Advanced Colorectal Cancer" (1 trials), "Advanced Stage IIIB" (1 trials), "Adverse Drug Event" (1 trials), "Autoinflammatory Syndrome, Unspecified" (1 trials) and "Behcet Syndrome" (1 trials). Many other conditions were trialed in "Ausl Di Piacenza" in a lesser frequency.

Most popular intervention types in "Ausl Di Piacenza" are "Drug" (21 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cisplatin" (2 trials), "Pemetrexed" (2 trials), "Aflibercept, 5fluorouracil, Folinic Acid andIrinotecan" (1 trials) and "Alectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ausl Di Piacenza" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ausl Di Piacenza". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ausl Di Piacenza, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ausl Di Piacenza, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Ausl Di Piacenza has several departments that took part in Clinical trials: "Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza" - 49 trials, "Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza" - 2 trials, "Unità Ematologia Ospedale Civile di Piacenza" - 2 trials, "UO Ematologia e CTMO di Piacenza" - 2 trials